Concepedia

Thomas Schliwa

TS

Statistics

Publications

4

Citations

92

H-Index

4

Active since

2013

Affiliations

Johann Heinrich von Thünen-Institut(Current)

Leipzig University

University Hospital Leipzig

Helios Vogtland Klinikum Plauen

Praxis für Hämatologie und Onkologie

Thomas Schliwa is an author at Johann Heinrich von Thünen-Institut specializing in multiple myeloma treatment, pharmacotherapy, and hematologic malignancy pharmacotherapy.

Publications per year

2013–2017

4

Publications

4

Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure

Wolfram Pönisch, Barbara Moll, Marc Andrea et al. · Journal of Cancer Research and Clinical Oncology · 2013 · 38 citations · Full text

, , +13

Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma

Wolfram Pönisch, Bruno Holzvogt, Madlen Plötze et al. · Journal of Cancer Research and Clinical Oncology · 2014 · 29 citations · Full text

, , +8

Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077)

Juliane Beck, Andreas Schwarzer, Dietrich Gläser et al. · Journal of Cancer Research and Clinical Oncology · 2017 · 14 citations · Full text

, , +14

Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma

Wolfram Poenisch, Madlen Plötze, Bruno Holzvogt et al. · Journal of Cancer Research and Clinical Oncology · 2015 · 11 citations · Full text

, , +16

1–4 of 4